BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2431636)

  • 1. Pharmacokinetics of procainamide hydrochloride in dogs.
    Papich MG; Davis LE; Davis CA; McKiernan BC; Brown SA
    Am J Vet Res; 1986 Nov; 47(11):2351-8. PubMed ID: 2431636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
    Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of coronary artery ligation on the pharmacokinetics of N-acetylprocainamide in dogs.
    Lai CM; Reynolds RD; Kamath BL; Calzadilla S; Gupta SD; Look ZM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):369-72. PubMed ID: 6158076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
    Jung D; Nanavaty M; Prasad P
    Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of N-acetylprocainamide.
    Atkinson AJ; Ruo TI
    Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantitative disposition of procainamide and N-acetylprocainamide in the rat.
    Schneck DW; Grove K; Dewitt FO; Shiroff RA; Hayes AH
    J Pharmacol Exp Ther; 1978 Jan; 204(1):219-25. PubMed ID: 619132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans.
    Tisdale JE; Rudis MI; Padhi ID; Svensson CK; Webb CR; Borzak S; Ware JA; Krepostman A; Zarowitz BJ
    J Clin Pharmacol; 1995 Sep; 35(9):902-10. PubMed ID: 8786250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of flunixin meglumine in dogs.
    Hardie EM; Hardee GE; Rawlings CA
    Am J Vet Res; 1985 Jan; 46(1):235-7. PubMed ID: 3970431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procainamide pharmacokinetics in beagles: urinary pH dependency and comparison with n-acetylprocainamide.
    Baer DT; Barkus JC
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):333-6. PubMed ID: 17895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of procainamide and N-acetylprocainamide in rats.
    Kamath BL; Lai CM; Gupta SD; Durrani MJ; Yacobi A
    J Pharm Sci; 1981 Mar; 70(3):299-302. PubMed ID: 6167709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of procainamide and its metabolite depending on acetylator phenotype].
    Gawrońska-Szklarz B; Górnik W; Kutrzeba J; Wójcicki J; Zakrzewski J
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):921-3. PubMed ID: 1284448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian changes in procainamide and N-acetylprocainamide kinetics in the rat.
    Bruguerolle B; Jadot G
    J Pharm Pharmacol; 1985 Sep; 37(9):654-6. PubMed ID: 2416904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of single doses of phenobarbital given intravenously and orally to dogs.
    Pedersoli WM; Wike JS; Ravis WR
    Am J Vet Res; 1987 Apr; 48(4):679-83. PubMed ID: 3592366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of thiamphenicol in dogs.
    Castells G; Intorre L; Franquelo C; Cristòfol C; Pérez B; Martí G; Arboix M
    Am J Vet Res; 1998 Nov; 59(11):1473-5. PubMed ID: 9829409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of N-acetylprocainamide from mixed diet in rats.
    Kamath BL; Yacobi A; Gupta SD; Stampfli H; Durrani M; Lai CM
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):299-308. PubMed ID: 6166034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular actions and pharmacokinetics of desethyl-N-acetylprocainamide in the dog.
    Lertora JJ; King LW
    J Pharmacol Exp Ther; 1986 Sep; 238(3):893-9. PubMed ID: 2427689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of an enzyme-multiplied immunoassay technique for determination of caffeine elimination kinetics as a test of liver function in clinically normal dogs.
    Golden DL; Spano JS; Wilson RC; DeGraves FJ; Whatley EM
    Am J Vet Res; 1994 Jun; 55(6):790-4. PubMed ID: 7944016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous predictions of disposition kinetics of procainamide and its metabolite N-acetylprocainamide in rat by a physiological pharmacokinetic model].
    Liu XD; Deng N; Huang SK
    Yao Xue Xue Bao; 1991; 26(10):725-32. PubMed ID: 1726674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis for severe procainamide toxicity: clinical and pharmacokinetic observations.
    Atkinson AJ; Krumlovsky FA; Huang CM; del Greco F
    Clin Pharmacol Ther; 1976 Nov; 20(5):585-92. PubMed ID: 975731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of procainamide in normal subjects using a specific gas chromatographic assay.
    Simons KJ; Levy RH; Cutler RE; Christopher GT; Lindner A
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):173-85. PubMed ID: 1153866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.